Page last updated: 2024-08-24

adamantylamide-alanyl-isoglutamine and Experimental Radiation Injuries

adamantylamide-alanyl-isoglutamine has been researched along with Experimental Radiation Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasná, A; Knötigová, P; Masek, K; Turánek, J; Vacek, A; Záluská, D1
Bláha, L; Borkovcová, P; Masek, K; Thurnvaldová, J; Turánek, J; Vacek, A; Záluská, D1

Other Studies

2 other study(ies) available for adamantylamide-alanyl-isoglutamine and Experimental Radiation Injuries

ArticleYear
Restoration of femoral GM-CFC progenitors in sublethally irradiated mice of various ages treated with liposomal adamantylamide dipeptide.
    International immunopharmacology, 2004, Volume: 4, Issue:8

    Topics: Aging; Amantadine; Animals; Cells, Cultured; Dipeptides; Dose-Response Relationship, Radiation; Female; Femur; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Liposomes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Radiation Injuries, Experimental; Radiation-Protective Agents

2004
Stimulation of nonspecific immunity, haemopoiesis and protection of mice against radiation injury by 1-adamantylamide-L-alanyl-D-isoglutamine incorporated in liposomes.
    International immunopharmacology, 2001, Volume: 1, Issue:1

    Topics: Adjuvants, Immunologic; Amantadine; Animals; Colony-Forming Units Assay; Dipeptides; Female; Hematopoiesis; Liposomes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Radiation Injuries, Experimental

2001